EUVIMEDEUVIMED entdecken
Open Access

In silico design and assessment of a multi-epitope peptide vaccine against multidrug-resistant Acinetobacter baumannii

Shiv Nandan Sah, Sumit Gupta, Neha Bhardwaj, Lalit Kumar Gautam, Neena Capalash, Prince Sharma iD

In Silico Pharmacology · 24.12.2024 · 13 (1)

DOI: 10.1007/s40203-024-00292-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift In Silico Pharmacology, online erschienen am 24.12.2024. Verfasst von Shiv Nandan Sah und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Panjab University, Chandigarh, 160014 India. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 122 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acinetobacter baumannii, an opportunistic and notorious nosocomial pathogen, is responsible for many infections affecting soft tissues, skin, lungs, bloodstream, and urinary tract, accounting for more than 722,000 cases annually. Despite the numerous advancements in therapeutic options, no approved vaccine is currently available for this particular bacterium. Consequently, this study focused on creating a rational vaccine design using bioinformatics tools. Three outer membrane proteins with immunogenic potential and properties of good vaccine candidates were used to select epitopes based on good antigenic properties, non-allergenicity, high binding scores, and a low IC50 value. A multi-epitope peptide (MEP) construct was created by sequentially linking the epitopes using suitable linkers. ClusPro 2.0 and C-ImmSim web servers were used for docking analysis with TLR2/TLR4 and immune response respectively. The Ramachandran plot showed an accurate model of the MEP with 100% residue in the most favored and allowed regions. The construct was highly antigenic, stable, non-allergenic, non-toxic, and soluble, and showed maximum population coverage. Additionally, molecular docking demonstrated strong binding between the designed MEP vaccine and TLR2/TLR4. In silico immunological simulations showed significant increases in T-cell and B-cell populations. Finally, codon optimization and in silico cloning were conducted using the pET-28a (+) plasmid vector to evaluate the efficiency of the expression of vaccine peptide in the host organism (Escherichia coli). This designed MEP vaccine would support and accelerate the laboratory work to develop a potent vaccine targeting MDR Acinetobacter baumannii. Supplementary Information: The online version contains supplementary material available at 10.1007/s40203-024-00292-3.

Schlagwörter

Stichwörter der Autor:innen

Acinetobacter baumanniiImmune-simulationIn silicoMolecular dockingMulti-epitope peptideVaccine

Autor:innen und Institutionen

  • Department of Microbiology, Panjab University, Chandigarh, 160014 India.
  • Department of Microbiology, Central Campus of Technology, Tribhuvan University, Dharan, Nepal.
  • School of Pharmaceutical Education and Research, Jamia Hamdard University, New Delhi, 110062 India.
  • Department of Anatomy and Cell Biology, University of Iowa, Iowa City, IA 52242 USA.
  • Department of Biotechnology, Panjab University, Chandigarh, 160014 India.

ORCID-Profile: Prince Sharma

Zitieren

APA

Sah, S. N., Gupta, S., Bhardwaj, N., Gautam, L. K., Capalash, N., & Sharma, P. (2024). In silico design and assessment of a multi-epitope peptide vaccine against multidrug-resistant Acinetobacter baumannii. In Silico Pharmacology, 13(1). https://doi.org/10.1007/s40203-024-00292-3

Vancouver

Sah SN, Gupta S, Bhardwaj N, Gautam LK, Capalash N, Sharma P. In silico design and assessment of a multi-epitope peptide vaccine against multidrug-resistant Acinetobacter baumannii. In Silico Pharmacology. 2024;13(1). doi:10.1007/s40203-024-00292-3

BibTeX
@article{Sah2024,
  author = {Sah, Shiv Nandan and Gupta, Sumit and Bhardwaj, Neha and Gautam, Lalit Kumar and Capalash, Neena and Sharma, Prince},
  title = {In silico design and assessment of a multi-epitope peptide vaccine against multidrug-resistant Acinetobacter baumannii},
  journal = {In Silico Pharmacology},
  year = {2024},
  volume = {13},
  number = {1},
  doi = {10.1007/s40203-024-00292-3}
}
Kostenlos starten →